In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...
Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...
MALES who are reluctant to seek medical advice when they feel discomfort will be targeted by health bodies across Barnsl...
AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...
A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...
Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...
University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer earlier. This tool may help guide treatment, such as signalling when to ...
News-Medical.Net on MSN
New trial tests strategies to protect heart health during prostate cancer therapy
City of Hope ® , one of the largest and most advanced cancer research and treatment organizations in the United States with ...
The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results